Tag: allergan

April 16, 2019

Biotech Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
May 8, 2018

Assembly Biosciences Announces First Quarter 2018 Financial Results

Assembly Biosciences (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B...
April 25, 2018

Daré Bioscience and Juniper Pharmaceuticals Enter Global License Agreement

In early trading on Wednesday, Daré’s share price increased nearly 73 percent before leveling at a 56.69-percent increase.
April 6, 2018

Is this the Next Botox? Evolus’s Phase 3 Study Met Primary Endpoints

Botox has long been one the best solutions for smoothing wrinkle lines, managing skin breakouts, lifting lips and more, but...
March 13, 2018

Investing in Alzheimer’s Treatments

What is the best way to start investing in Alzheimer's treatments? The space has proven difficult for companies to break...
February 8, 2018

How Are Pharma Stocks Affected by Opioid Lawsuits?

Since the news about the lawsuits starting in 2016, Insys share price has dropped 65.56 percent from $28.63 to $9.62,...